3-HKA Promotes Vascular Remodeling After Stroke by Modulating the Activation of A1/A2 Reactive Astrocytes

Area of Science:

• Neuroscience
• Biochemistry
• Vascular Biology

Background:

• Ischemic stroke is a leading cause of global disability, with prognosis linked to tryptophan metabolism.
• Abnormal tryptophan metabolism, specifically reduced 3-hydroxy-kynurenamine (3-HKA), is observed in stroke patients and models.

Purpose of the Study:

• To investigate the role of 3-hydroxy-kynurenamine (3-HKA) in ischemic stroke recovery.
• To explore the therapeutic potential of 3-HKA supplementation in stroke models.

Main Methods:

• Identified 3-HKA downregulation in stroke patients and animal models.
• Administered 3-HKA in a middle cerebral artery occlusion (MCAO) model to assess effects on neurological recovery, infarct volume, and cerebral blood flow.
• Utilized proteomic analysis and co-culture systems to examine 3-HKA's impact on angiogenesis, blood-brain barrier (BBB) repair, astrocyte polarization, and AIM2 inflammasome activation.

Main Results:

• 3-HKA supplementation improved neurological recovery, reduced infarct volume, and increased cerebral blood flow post-MCAO.
• 3-HKA promoted angiogenesis, BBB repair, and shifted astrocyte polarization towards a neuroprotective A2 phenotype.
• 3-HKA inhibited AIM2 inflammasome activation in astrocytes, a key factor in stroke-induced vascular remodeling.

Conclusions:

• 3-hydroxy-kynurenamine (3-HKA) demonstrates significant therapeutic potential for ischemic stroke.
• 3-HKA promotes post-stroke vascular remodeling and neurological recovery by regulating astrocyte activation and inhibiting AIM2 inflammasome.
• Supplementation with 3-HKA may represent a novel and effective treatment strategy for stroke patients.